J&J begins trial of two-dose COVID-19 vaccine regimenJohnson & Johnson has begun a second phase 3 trial of its potential COVID-19 vaccine, including sites in Share XJ&J begins trial of two-dose COVID-19 vaccine regimenhttps://pharmaphorum.com/news/jj-begins-trial-of-two-dose-covid-19-vaccine-regimen/
Bayer data for kidney disease hope finerenone sets up filingsBayer’s blockbuster ambitions for diabetic kidney disease (DKD) drug candidate finerenone look a lot firmer with the publication Share XBayer data for kidney disease hope finerenone sets up filingshttps://pharmaphorum.com/news/bayer-data-for-kidney-disease-hope-finerenone-sets-up-filings/
AZ, J&J COVID-19 vaccine trials okay to restart in USUS trials of AstraZeneca’s experimental COVID-19 vaccine AZD1222 have been cleared to restart by the FDA, several weeks Share XAZ, J&J COVID-19 vaccine trials okay to restart in UShttps://pharmaphorum.com/news/az-jj-coronavirus-vaccine-trials-okay-to-restart-in-us/
J&J’s late-stage COVID-19 vaccine trial halted after ‘unexplained illness’Johnson & Johnson has paused further dosing in its COVID-19 vaccine clinical trial following an “unexplained illness” in Share XJ&J’s late-stage COVID-19 vaccine trial halted after ‘unexplained illness’https://pharmaphorum.com/news/jjs-late-stage-covid-19-vaccine-trial-halted-after-unexplained-illness/
EU ramps up supply of COVID-19 vaccine, drugsThe European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after Share XEU ramps up supply of COVID-19 vaccine, drugshttps://pharmaphorum.com/news/eu-ramps-up-supply-of-covid-19-vaccine-drugs/
J&J settles 1,000 talc lawsuits for $100m+; reportJohnson & Johnson has agreed to pay more than $100 million to settle over 1,000 lawsuits that allege Share XJ&J settles 1,000 talc lawsuits for $100m+; reporthttps://pharmaphorum.com/news/j-report/
Drama as J&J partner Legend’s CEO is detained after Chinese customs raidsJust a month after taking up the CEO role at Legend Biotech, Frank Zhang has been forced to Share XDrama as J&J partner Legend’s CEO is detained after Chinese customs raidshttps://pharmaphorum.com/news/drama-as-jj-partner-legends-ceo-is-detained-after-chinese-customs-raids/
Janssen files Darzalex Faspro for rare disease light chain amyloidosisJanssen has filed a new formulation of its Darzalex in the US for the rare and potentially fatal Share XJanssen files Darzalex Faspro for rare disease light chain amyloidosishttps://pharmaphorum.com/news/janssen-files-new-darzalex-for-rare-disease-light-chain-amyloidosis/
Despite biosims, ulcerative colitis drugs still cost too much; ICERNone of the immune-modulating drugs approved to treat ulcerative colitis – even biosimilars – are priced low enough Share XDespite biosims, ulcerative colitis drugs still cost too much; ICERhttps://pharmaphorum.com/news/despite-biosims-ulcerative-colitis-drugs-still-cost-too-much-icer/
